Effects of synbiotic consumption on lipid profile: a systematic review and meta-analysis of randomized controlled clinical trials

No abstract is available for this paper.

• Publication year

  2020

• Venue

  European Journal of Nutrition

• Publication date

  2020-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00394-020-02248-7PMID 32322969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD

  2019cited by this paper
• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

  2019cited by this paper
• Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

  2019cited by this paper
• Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

  2019cited by this paper
• The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial

  2019cited by this paper
• Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.

  2018cited by this paper
• Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials

  2018cited by this paper
• Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

  2018cited by this paper
• The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial

  2018cited by this paper
• Effect of the consumption of a synbiotic diet mousse containing Lactobacillus acidophilus La-5 by individuals with metabolic syndrome: A randomized controlled trial

  2018cited by this paper
• The Effects of Synbiotic Supplementation on Metabolic Status in Diabetic Patients Undergoing Hemodialysis: a Randomized, Double-Blinded, Placebo-Controlled Trial

  2018cited by this paper
• The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study

  2017cited by this paper
• Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial

  2017cited by this paper
• Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial

  2017cited by this paper
• Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial

  2017cited by this paper
• The Potential Role of Probiotics or / and Prebiotic on Serum Lipid Profile and Insulin Resistance in Alcoholic Fatty Liver Disease : A Double Blind Randomized Clinical Trial

  2017cited by this paper
• Effects of curcumin on HDL functionality

  2017cited by this paper
• Dysbiosis in gastrointestinal disorders.

  2016cited by this paper
• The role of the gut microbiota in NAFLD

  2016cited by this paper
• Randomized controlled trial

  2016influential reference
• Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis

  2016cited by this paper
• Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial

  2016cited by this paper
• A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with Coronary Heart Disease

  2015cited by this paper
• Influence of daily consumption of synbiotic soy-based product supplemented with okara soybean by-product on risk factors for cardiovascular diseases

  2015cited by this paper
• Innate immune pattern recognition: a cell biological perspective.

  2015cited by this paper
• Dysbiosis of the gut microbiota in disease

  2015cited by this paper
• Gut microbiota and obesity

  2015cited by this paper
• Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels While Increasing HDL Levels in Serum from Patients with Type-2 Diabetes

  2014cited by this paper
• Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study

  2014cited by this paper
• Effect of the Synbiotic (B. animalis spp. lactis Bb12 + Oligofructose) in Obese Subjects. A Randomized, Double-Blind, Controlled Clinical Trial

  2014cited by this paper
• Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.

  2014cited by this paper
• Pharmacology, physiology, and mechanisms of incretin hormone action.

  2013cited by this paper
• Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double‐blind, placebo‐controlled crossover study

  2013cited by this paper
• Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women

  2013cited by this paper
• GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

  2012cited by this paper
• Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

  2012cited by this paper
• Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus

  2012cited by this paper
• Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities

  2012cited by this paper
• Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics

  2012cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

  2010cited by this paper
• Correspondence to Author:

  2010cited by this paper
• Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  2010cited by this paper
• Probiotic Bile Salt Hydrolase: Current Developments and Perspectives

  2010cited by this paper
• Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol.

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions

  2008cited by this paper
• Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters.

  2008cited by this paper
• Probiotics, prebiotics, and synbiotics.

  2008cited by this paper
• Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.

  2007cited by this paper
• Mellitus: A Scientific Statement From the American Heart Association and the Primary Prevention of Cardiovascular Diseases in People With Diabetes

  2007cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions Edited by Julian P. T. Higgins &

  2006cited by this paper
• Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

  2006cited by this paper
• Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, Ethnicity, and Coronary Artery Calcium

  2006cited by this paper
• Bile Salt Hydrolase Activity in Probiotics

  2006cited by this paper
• Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

  2004cited by this paper
• Cholesterol removal from media by lactococci.

  2002cited by this paper
• [Detection, evaluation, and treatment of high blood cholesterol in adults].

  2001cited by this paper
• Inhibition of Human Gastric Lipase Secretion by Glucagon-like Peptide-1

  1998cited by this paper
• Variance imputation for overviews of clinical trials with continuous response.

  1992cited by this paper
• Effects of physical activity on risk factors for coronary heart disease in previously sedentary women: a five-year longitudinal study.

  1988cited by this paper

• An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial

  2025influential citation
• The effect of probiotics, prebiotics and synbiotics on gut microbial community profile in overweight and obese Latin American and Caribbean populations: a systematic review of human trials

  2025cites this paper
• Functional Beverages From Frankincense and Pistacia atlantica: A Natural Synbiotic Strategy for Managing Hyperlipidemia and Modulating Gut Microbiota

  2025cites this paper
• Synbiotic Administration of d‐Tagatose and Lacticaseibacillus casei ATCC 393 Improves Hyperlipidemia in BALB/c Mice by Modulating Gut Microbiota and Metabolic Parameters

  2025cites this paper
• Effect of synbiotics on the cardiovascular risk factors in patients with non-alcoholic fatty liver: a GRADE assessed systematic review and meta-analysis

  2025cites this paper
• Gut microbiota alteration - cancer relationships and synbiotic roles in cancer therapies

  2024cites this paper
• The effect of supplementation with a multi-species synbiotic on serum lipid profile, abundance of beneficial gut bacteria and firmicutes to bacteroidetes ratio in patients with dyslipidemia; a randomized, double-blind, placebo-controlled, clinical trial

  2024cites this paper
• Randomized clinical trial evaluating the efficacy of synbiotic supplementation on serum endotoxin and trimethylamine N-oxide levels in patients with dyslipidaemia

  2024cites this paper
• Multi-species synbiotic supplementation increased fecal short chain fatty acids and anti-inflammatory cytokine interleukin-10 in adult men with dyslipidemia; A randomized, double-blind, clinical trial.

  2024cites this paper
• Effects of multi-species synbiotic supplementation on circulating miR-27a, miR-33a levels and lipid parameters in adult men with dyslipidaemia; a randomised, double-blind, placebo-controlled clinical trial

  2024cites this paper
• The effect of a new developed synbiotic yogurt consumption on metabolic syndrome components in adults with metabolic syndrome: a randomized controlled clinical trial

  2024cites this paper
• Effects of synbiotics surpass probiotics alone in improving type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial.

  2024cites this paper
• Effect of Ajwa Date and Germinated Barley on Lipid Profile in Rats Fed High-Fat Diet

  2023cites this paper
• Effects of Probiotic and Selenium Co-supplementation on Lipid Profile and Glycemia Indices: A Systematic Review and Meta-analysis of Randomized Clinical Trials

  2023cites this paper
• Effects of synbiotics supplementation on anthropometric and lipid profile parameters: Finding from an umbrella meta-analysis

  2023influential citation
• Comparison of the Effects of Prebiotics and Synbiotics Supplementation on the Immune Function of Male University Football Players

  2023cites this paper
• Probiotic potential of the Indonesian local variety of fermented parboiled rice (tape) improved the metabolic syndrome of diabetic rats

  2023cites this paper
• Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases

  2023cites this paper
• Effect of Probiotic Supplementation on FSH, LH Levels and Folliculogenesis

  2023cites this paper
• Exploring the Relationship between the Gut Microbiota and Ageing: A Possible Age Modulator

  2023cites this paper
• Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials

  2023cites this paper
• Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial

  2023cites this paper
• Effects of probiotic supplementation on hormonal and clinical outcomes of women diagnosed with polycystic ovary syndrome: A double-blind, randomized, placebo-controlled clinical trial

  2022cites this paper
• The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease

  2022cites this paper
• Effect of synbiotic bread containing lactic acid on blood lipids and apolipoproteins in patients with type 2 diabetes: A randomized controlled trial

  2022cites this paper
• Synbiotic Supplementation Improves Obesity Index and Metabolic Biomarkers in Thai Obese Adults: A Randomized Clinical Trial

  2021cites this paper
• Metabolic syndrome and synbiotic targeting of the gut microbiome

  2021cites this paper
• Effect of Probiotic Consumption on Immune Response in Athletes: A Meta-analysis

  2021cites this paper
• Therapeutic modulation methods of gut microbiota and gut-liver axis

  2021cites this paper
• Probiotics, Prebiotics, Synbiotics, Postbiotics and Other Biotics. What's Next?

  2021cites this paper
• Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases

  2021cites this paper
• Gut microbiota and old age: Modulating factors and interventions for healthy longevity

  2020cites this paper